N. G. Bader El Din

发表

A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients

Reham M. Dawood, A. Tabll, A. Massoud, 2013, Hepatitis monthly.

Predictors of Disease Recurrence Post Living Donor Liver Transplantation in End Stage Chronic HCV Patients

T. Elbaz, Tawfeek H. Abdelhafez, Noha G Bader El Din, 2014, Disease markers.

Dysregulation of fibrosis related genes in HCV induced liver disease.

A. Barakat, Noha G Bader El Din, M. E. El Awady, 2018, Gene.

Vascular Endothelial Growth Factor Expression in Hepatitis C Virus-Induced Liver Fibrosis: A Potential Biomarker.

Noha G Bader El Din, M. E. El Awady, Ghada M. Salum, 2017, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

MicroRNAs expression profiling in Egyptian colorectal cancer patients

N. Zayed, Noha G Bader El Din, Reem El-Shenawy, 2019, IUBMB life.

The potential value of miRNA-223 as a diagnostic biomarker for Egyptian colorectal patients

Noha G Bader El Din, Lubna O. Abdel-Salam, Ahmed Khairy, 2020, European journal of gastroenterology & hepatology.

Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients

Reham M. Dawood, A. Salem, N. Zayed, 2016, World journal of gastroenterology.

The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 Patients

A. Salem, G. B. E. DinNoha, FaroukSally, 2017 .

The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 Patients.

A. Salem, Reem El-Shenawy, M. E. El Awady, 2017, Viral immunology.

Differential Expression of miR-21, miR-23a, and miR-27a, and Their Diagnostic Significance in Egyptian Colorectal Cancer Patients.

A. Salem, A. Soliman, Noha G Bader El Din, 2020, Genetic testing and molecular biomarkers.

Antiviral Activity of Virocidal Peptide Derived from NS5A against Two Different HCV Genotypes: An in vitro Study

M. El-Awady, Y. E. El Abd, A. Tabll, 2015, Journal of immunoassay & immunochemistry.

Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease

M. El-Awady, Y. E. El Abd, A. Tabll, 2012, Hepatitis monthly.

Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis

A. Barakat, Noha G Bader El Din, M. E. El Awady, 2016, PloS one.

Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC.

M. Khairy, A. Elsharkawy, A. Yosry, 2022, Laboratoriums Medizin.

Expression of Reactive Oxygen Species–Related Transcripts in Egyptian Children With Autism

N. Meguid, Magda F. Mohamed, Tawfeek H. Abdelhafez, 2017, Biomarker insights.

Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy

H. Sharada, M. S. Abdalla, A. Helmy, 2011, Journal of gastroenterology and hepatology.

A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice

J. Dubuisson, Reham M. Dawood, Tawfeek H. Abdelhafez, 2019, BMC Infectious Diseases.

Mice Antibody Response to Conserved Nonadjuvanted Multiple Antigenic Peptides Derived from E1/E2 Regions of Hepatitis C Virus.

M. El-Awady, A. Tabll, Tawfeek H. Abdelhafez, 2017, Viral immunology.

WITHDRAWN: Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy.

I. Waked, Reham M. Dawood, M. El-Awady, 2013, Vaccine.

Human cytomegalovirus infection inhibits response of chronic hepatitis‐C‐virus‐infected patients to interferon‐based therapy

A. Barakat, A. Helmy, A. Tabll, 2011, Journal of gastroenterology and hepatology.

The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patients.

S. Abd-Elsalam, D. Omran, Noha G Bader El Din, 2021, Microbial pathogenesis.

Polymorphism in Variable Number of Tandem Repeats of Dopamine D4 Gene Is a Genetic Risk Factor in Attention Deficit Hyperactive Egyptian Children: Pilot Study

N. Meguid, Noha G Bader El Din, M. E. El Awady, 2015, Biomarker insights.

Polymorphism in Variable Number of Tandem Repeats of Dopamine D4 Gene Is a Genetic Risk Factor in Attention Deficit Hyperactive Egyptian Children: Pilot Study

N. Meguid, M. E. El Awady, O. Shahin, 2015, Biomarker insights.

Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients

I. Khalil, Y. E. El Abd, N. Zayed, 2015 .

Increased incidence of cytomegalovirus coinfection in HCV-infected patients with late liver fibrosis is associated with dysregulation of JAK-STAT pathway

A. Khedr, Noha G Bader El Din, M. E. El Awady, 2017, Scientific Reports.

Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis

M. Bahgat, Y. E. El Abd, A. Tabll, 2006, Virology Journal.

Vascular Endothelial Growth Factor Expression in Hepatitis C Virus-Induced Liver Fibrosis: A Potential Biomarker.

G. B. E. DinNoha, K. IbrahimMarwa, M. DawoodReham, 2017, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Murine neutralizing antibody response and toxicity to synthetic peptides derived from E1 and E2 proteins of hepatitis C virus.

A. el-Zayadi, M. El-Awady, A. Tabll, 2010, Vaccine.

IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients.

A. Tabll, Tawfeek H. Abdelhafez, Noha G Bader El Din, 2013, World journal of gastroenterology.